Sascha Kretschmann

3.2k total citations · 1 hit paper
8 papers, 109 citations indexed

About

Sascha Kretschmann is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Sascha Kretschmann has authored 8 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Sascha Kretschmann's work include CAR-T cell therapy research (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Sascha Kretschmann is often cited by papers focused on CAR-T cell therapy research (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Sascha Kretschmann collaborates with scholars based in Germany, Netherlands and United Kingdom. Sascha Kretschmann's co-authors include Georg Schett, Andréas Mackensen, Michael Aigner, Simon Völkl, Fabian Müller, Jule Taubmann, Armin Atzinger, Michael Uder, Torsten Kuwert and Regina Gary and has published in prestigious journals such as Nature Medicine, Blood and Frontiers in Immunology.

In The Last Decade

Sascha Kretschmann

7 papers receiving 107 citations

Hit Papers

BCMA CAR T cells in a patient with relapsing idiopathic i... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sascha Kretschmann Germany 5 79 56 25 20 15 8 109
Marta Español‐Rego Spain 9 52 0.7× 52 0.9× 43 1.7× 22 1.1× 16 1.1× 15 149
Carlo Tur Germany 3 39 0.5× 42 0.8× 11 0.4× 11 0.6× 7 0.5× 10 87
Juliane K. Lohmeyer United States 8 114 1.4× 173 3.1× 30 1.2× 10 0.5× 17 1.1× 15 225
Benjamin J. Uttenthal United Kingdom 6 81 1.0× 54 1.0× 36 1.4× 6 0.3× 21 1.4× 9 135
Dominik Trzupek United Kingdom 4 43 0.5× 94 1.7× 35 1.4× 12 0.6× 31 2.1× 6 156
Michael J. Sikora Germany 3 45 0.6× 145 2.6× 49 2.0× 16 0.8× 4 0.3× 3 205
Feiya Ou United States 7 62 0.8× 138 2.5× 41 1.6× 21 1.1× 10 0.7× 14 206
Jules Russick France 6 42 0.5× 72 1.3× 32 1.3× 6 0.3× 14 0.9× 10 142
Artur Wilhelm Germany 4 46 0.6× 57 1.0× 13 0.5× 8 0.4× 11 0.7× 4 104
Léa Flippe France 6 33 0.4× 76 1.4× 57 2.3× 8 0.4× 18 1.2× 9 150

Countries citing papers authored by Sascha Kretschmann

Since Specialization
Citations

This map shows the geographic impact of Sascha Kretschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sascha Kretschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sascha Kretschmann more than expected).

Fields of papers citing papers by Sascha Kretschmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sascha Kretschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sascha Kretschmann. The network helps show where Sascha Kretschmann may publish in the future.

Co-authorship network of co-authors of Sascha Kretschmann

This figure shows the co-authorship network connecting the top 25 collaborators of Sascha Kretschmann. A scholar is included among the top collaborators of Sascha Kretschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sascha Kretschmann. Sascha Kretschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Müller, Fabian, Andreas Wirsching, Melanie Hagen, et al.. (2025). BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells. Nature Medicine. 31(6). 1793–1797. 15 indexed citations breakdown →
2.
Taubmann, Jule, Johannes Knitza, Fabian Müller, et al.. (2023). Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies. Lara D. Veeken. 63(1). e12–e14. 55 indexed citations
3.
Taubmann, Jule, Johannes Knitza, Fabian Müller, et al.. (2023). Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell–depleting antibodies: reply. Lara D. Veeken. 63(11). e312–e314. 2 indexed citations
4.
Taubmann, Jule, Simon Voelkl, Laura Bucci, et al.. (2023). CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients. Blood. 142(Supplement 1). 220–220. 9 indexed citations
5.
Kretschmann, Sascha, Simon Völkl, Hannah Reimann, et al.. (2022). Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus. Transplantation and Cellular Therapy. 29(1). 27–33. 22 indexed citations
6.
Voelkl, Simon, Dimitrios Mougiakakos, Sebastian Boeltz, et al.. (2022). CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients. Blood. 140(Supplement 1). 4562–4563. 1 indexed citations
7.
Reimann, Hannah, Sascha Kretschmann, Edith D. van der Meijden, et al.. (2021). Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens. Journal for ImmunoTherapy of Cancer. 9(7). e002401–e002401.
8.
Kremer, Anita N., Ellie G.A. Lurvink, Andreas E. Kremer, et al.. (2020). Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase. Frontiers in Immunology. 11. 381–381. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026